Amit Lazarov1, Sofi Marom2, Naomi Yahalom2, Daniel S Pine3, Haggai Hermesh4, Yair Bar-Haim5. 1. Department of Psychiatry,Columbia University Medical Center,1051 Riverside Drive, New York, NY 10032,USA. 2. Anxiety Disorders and Behavior Therapy Unit, Outpatient Department,Geha Mental Health Center, Tel-Aviv University,Tel-Aviv,Israel. 3. Section on Developmental Affective Neuroscience,National Institute of Mental Health,Bethesda, Maryland,USA. 4. Anxiety Disorders and Behavior Therapy Unit, Outpatient Department,Geha Mental Health Center and Sackler Faculty of Medicine, Tel Aviv University,Tel-Aviv,Israel. 5. School of Psychological Sciences and Sagol School of Neuroscience, Tel Aviv University,Tel-Aviv,Israel.
Abstract
BACKGROUND:Cognitive-behavioral group therapy (CBGT) is a first-line treatment for social anxiety disorder (SAD). However, since many patients remain symptomatic post-treatment, there is a need for augmenting procedures. This randomized controlled trial (RCT) examined the potential augmentation effect of attention bias modification (ABM) for CBGT. METHODS:Fifty patients with SAD from three therapy groups were randomized to receive an 18-week standard CBGT with either ABM designed to shift attention away from threat (CBGT + ABM), or a placebo protocol not designed to modify threat-related attention (CBGT + placebo). Therapy groups took place in a large mental health center. Clinician and self-report measures of social anxiety and depression were acquired pre-treatment, post-treatment, and at 3-month follow-up. Attention bias was assessed at pre- and post-treatment. RESULTS: Patients randomized to the CBGT + ABM group, relative to those randomized to the CBGT + placebo group, showed greater reductions in clinician-rated SAD symptoms post-treatment, with effects maintained at 3-month follow-up. Group differences were not evident for self-report or attention-bias measures, with similar reductions in both groups. Finally, reduction in attention bias did not mediate the association between group and reduction in Liebowitz Social Anxiety Scale Structured Interview (LSAS) scores. CONCLUSIONS: This is the first RCT to examine the possible augmenting effect of ABM added to group-based cognitive-behavioral therapy for adult SAD. Training patients' attention away from threat might augment the treatment response to standard CBGT in SAD, a possibility that could be further evaluated in large-scale RCTs.
RCT Entities:
BACKGROUND: Cognitive-behavioral group therapy (CBGT) is a first-line treatment for social anxiety disorder (SAD). However, since many patients remain symptomatic post-treatment, there is a need for augmenting procedures. This randomized controlled trial (RCT) examined the potential augmentation effect of attention bias modification (ABM) for CBGT. METHODS: Fifty patients with SAD from three therapy groups were randomized to receive an 18-week standard CBGT with either ABM designed to shift attention away from threat (CBGT + ABM), or a placebo protocol not designed to modify threat-related attention (CBGT + placebo). Therapy groups took place in a large mental health center. Clinician and self-report measures of social anxiety and depression were acquired pre-treatment, post-treatment, and at 3-month follow-up. Attention bias was assessed at pre- and post-treatment. RESULTS:Patients randomized to the CBGT + ABM group, relative to those randomized to the CBGT + placebo group, showed greater reductions in clinician-rated SAD symptoms post-treatment, with effects maintained at 3-month follow-up. Group differences were not evident for self-report or attention-bias measures, with similar reductions in both groups. Finally, reduction in attention bias did not mediate the association between group and reduction in Liebowitz Social Anxiety Scale Structured Interview (LSAS) scores. CONCLUSIONS: This is the first RCT to examine the possible augmenting effect of ABM added to group-based cognitive-behavioral therapy for adult SAD. Training patients' attention away from threat might augment the treatment response to standard CBGT in SAD, a possibility that could be further evaluated in large-scale RCTs.
Entities:
Keywords:
attention bias; attention bias modification (ABM); cognitive-behavioral group therapy (CBGT); social anxiety disorder
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Falk Leichsenring; Simone Salzer; Manfred E Beutel; Stephan Herpertz; Wolfgang Hiller; Juergen Hoyer; Johannes Huesing; Peter Joraschky; Bjoern Nolting; Karin Poehlmann; Viktoria Ritter; Ulrich Stangier; Bernhard Strauss; Nina Stuhldreher; Susan Tefikow; Tobias Teismann; Ulrike Willutzki; Joerg Wiltink; Eric Leibing Journal: Am J Psychiatry Date: 2013-07 Impact factor: 18.112
Authors: Alexandra M Rodman; Jessica L Jenness; David G Weissman; Daniel S Pine; Katie A McLaughlin Journal: Biol Psychiatry Date: 2019-05-10 Impact factor: 13.382
Authors: Amit Lazarov; Benjamin Suarez-Jimenez; Rany Abend; Reut Naim; Erel Shvil; Liat Helpman; Xi Zhu; Santiago Papini; Ariel Duroski; Rony Rom; Franklin R Schneier; Daniel S Pine; Yair Bar-Haim; Yuval Neria Journal: Psychol Med Date: 2018-11-12 Impact factor: 7.723
Authors: Amit Lazarov; Dana Basel; Sarah Dolan; Daniel G Dillon; Diego A Pizzagalli; Franklin R Schneier Journal: J Affect Disord Date: 2021-05-01 Impact factor: 6.533